相关实验视频
Updated: May 5, 2026

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.2K
早期新生儿败血症下炎症的分子机制:人类研究的系统审查
Anca Vulcănescu1,2, Mirela-Anișoara Siminel1,3, Anda-Lorena Dijmărescu1,4
1"Filantropia" Clinical Municipal Hospital, 200143 Craiova, Romania.
Journal of clinical medicine
|August 14, 2025
概括
早期新生儿败血症 (EOS) 涉及由感染和无菌过程引起的复杂炎症. 了解这些分子通路对于更好的诊断和有针对性的治疗来改善婴儿健康至关重要.
科学领域:
- 新生儿医学 新生儿医学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 早发性新生儿败血症 (EOS) 是婴儿疾病和死亡的重要原因.
- 由于非特异性症状和延迟的实验室结果,诊断EOS具有挑战性.
- 了解EOS分子机制对于早期检测和治疗至关重要.
研究的目的:
- 审查EOS病变发生过程中的分子途径.
- 专注于炎症,免疫反应和诊断战略.
- 综合有关EOS分子机制的当前知识.
主要方法:
- 从2015年1月到2025年1月对研究进行系统审查.
- 包括对人类新生儿的研究,分析了EOS的分子/免疫机制.
- 专注于致病,免疫失调和诊断.
主要成果:
- 病原体驱动的炎症包括TLRs,中性粒细胞和细胞因子 (IL-6,IL-1β,TNF-α).
- 系统性反应显示了细胞因子失调和多器官功能障碍.
- 无菌炎症和通路相互作用加剧组织损伤;新的生物标志物显示出诊断的希望.
结论:
- EOS是由结合的传染性和无菌性炎症过程引起的.
- 更深入的分子洞察力可以改善EOS诊断和治疗.
- 基于分子理解的有针对性的方法承诺更好的新生儿结果.
相关概念视频
Development of Human Microbiota
68
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
Acute Inflammation II: Local and Systemic Effects
82
Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
82
Bacterial Meningitis II: Pathophysiology
45
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
45

